ARCHIVES

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter takes summer publication break, back Sept. 12.

August 8, 2003

Simons Named CEO of Prostate Cancer Foundation.

November 17, 2006

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

NCI Charging Use Fee for Compounds In Repository

August 12, 1983

Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says

August 29, 2008

Conferees Agree On Extension Of Biomedical Research Authorities For Two Years; Kennedy-Waxman Bills Are Dead

November 28, 1980